Abstract
WED-441 - A novel orally available type IV autotaxin inhibitor, IOA-289, ameliorates steatosis and fibrosis in a preclinical model of non-alcoholic steatohepatitis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have